Melinta Therapeutics, Inc. Asset Turnover Ratio (CEMP), as of third quarter 2019, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Melinta Therapeutics, Inc.  (CEMP)
 

Melinta Therapeutics Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Melinta Therapeutics's asset turnover ratio, the ratio that measures the ability of Melinta Therapeutics's assets to generate revenue, sequentially decreased to 0.21 in the third quarter (Sep 30 2019), but it does not raise any concerns as Melinta Therapeutics continue to execute well, and the asset turnover ratio remains above the average.

Within sector 145 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2019 compared to the preceding quarter from 3003 to 3004.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CEMP Asset Turnover Ratio (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter
Y / Y Asset Change -52.62 % -14.43 % 4.84 % 163.11 % 168.12 %
Y / Y Revenue Change -53.43 % 32.72 % -5.1 % 738.79 % 967.94 %
Asset Turnover Ratio (TTM) 0.21 0.22 0.2 0.2 0.16
CEMP's Total Ranking # 3004 # 3003 # 3003 # 3002 # 0
Seq. Asset Change -48.11 % -6.39 % 6.54 % -8.44 % -6.28 %
Seq. Revenue Change -0.53 % 13.28 % -60.31 % 4.14 % 183.46 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 146
Healthcare Sector # 408
Overall Market # 3004

Asset Turnover Ratio Statistics
High Average Low
0.22 0.14 0.07
(Jun 30 2019)   (Jun 30 2016)




CEMP Company Profile • Back to CEMP Efficiency Comparisons • Compare CEMP Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2019, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2019 Assets at quarter ending Sep 30 2019
Accuray Incorporated  0.98 $ 412.533  Millions$ 421.697  Millions
Clearpoint Neuro Inc   0.98 $ 10.283  Millions$ 10.535  Millions
Universal Health Services Inc   0.97 $ 11,236.508  Millions$ 11,583.452  Millions
Orthofix Medical Inc   0.96 $ 459.539  Millions$ 477.592  Millions
Neurometrix Inc   0.96 $ 11.294  Millions$ 11.805  Millions
Seaspine Holdings Corporation  0.95 $ 153.369  Millions$ 160.850  Millions
Regen Biopharma Inc   0.94 $ 0.110  Millions$ 0.117  Millions
Pressure Biosciences Inc   0.93 $ 2.217  Millions$ 2.390  Millions
Biomerica Inc   0.92 $ 5.122  Millions$ 5.565  Millions
Inogen Inc   0.92 $ 369.557  Millions$ 403.150  Millions
Penumbra Inc  0.92 $ 522.935  Millions$ 570.769  Millions
U S Physical Therapy Inc  0.91 $ 477.204  Millions$ 522.114  Millions
Option Care Health Inc   0.90 $ 1,169.921  Millions$ 1,301.976  Millions
Bruker Corporation  0.89 $ 2,026.300  Millions$ 2,268.225  Millions
Genmark Diagnostics Inc   0.89 $ 80.203  Millions$ 90.467  Millions
Natera Inc   0.88 $ 286.053  Millions$ 323.298  Millions
Pra Health Sciences Inc   0.88 $ 2,995.670  Millions$ 3,391.258  Millions
Carlisle Companies Incorporated  0.88 $ 4,744.600  Millions$ 5,372.175  Millions
Thermogenesis Holdings Inc   0.87 $ 14.013  Millions$ 16.091  Millions
Varian Medical Systems Inc   0.87 $ 3,225.100  Millions$ 3,707.500  Millions
Glaukos Corp  0.86 $ 225.211  Millions$ 261.131  Millions
West Pharmaceutical Services Inc   0.86 $ 1,791.800  Millions$ 2,078.075  Millions
Corcept Therapeutics Inc  0.86 $ 285.422  Millions$ 331.902  Millions
Perspective Therapeutics Inc   0.86 $ 8.067  Millions$ 9.395  Millions
National Vision Holdings Inc   0.85 $ 1,678.490  Millions$ 1,966.185  Millions
Vystar Corporation  0.85 $ 6.509  Millions$ 7.654  Millions
Harrow Inc   0.85 $ 49.945  Millions$ 58.954  Millions
Nevro Corp   0.84 $ 383.825  Millions$ 454.240  Millions
Caredx Inc   0.84 $ 114.756  Millions$ 136.574  Millions
Establishment Labs Holdings Inc   0.84 $ 81.713  Millions$ 97.277  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.